Table 1. Expression of ATDC in the cases of NSCLC stratified by their clinicopathological parameters.

Characteristics	Number of patients	ATDC negative	ATDC positive	P
Age
<60	59	27(45.76%)	32(54.24%)	0.5449
≥60	50	20(40.00%)	30(60.00%)
Gender
Male	61	24(39.34%)	37(60.66%)	0.3696
Female	48	23(47.92%)	25(52.08%)
Histology
Adenocarcinoma	63	46(73.02%)	17(26.98%)	<0.0001
Squamous cell carcinoma	46	1(2.17%)	45(97.83%)
Differentiation
Well	35	24(68.57%)	11(31.43%)	0.0002
Moderate- Poor	74	23 (31.08%)	51(68.92%)
TNM stage
I	48	19(39.58%)	29(60.42%)	0.5085
II+III	61	28(45.90%)	33(54.10%)
Tumor status
T1	38	22(57.89%)	16(42.11%)	0.0227
T2 T3 T4	71	25(35.21%)	46(64.79%)
Nodal status
N0	65	25(38.46%)	40(61.54%)	0.2327
N1 N2 N3	44	22(50.00%)	22(50.00%)
Ki67
Low	49	29(59.18%)	20(40.82%)	0.0022
High	60	18(30.00%)	42(70.00%)
cyclin D1
Low	39	25(64.10%)	14(35.90%)	0.0010
High	70	22(34.14%)	48(64.86%)
c-Myc
Low	72	37(51.39%)	35(48.61%)	0.0150
High	37	10(27.03%)	27(72.97%)